A detailed history of Green Alpha Advisors, LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Green Alpha Advisors, LLC holds 12,636 shares of TWST stock, worth $586,184. This represents 0.51% of its overall portfolio holdings.

Number of Shares
12,636
Previous 15,085 16.23%
Holding current value
$586,184
Previous $517,000 20.31%
% of portfolio
0.51%
Previous 0.38%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$27.95 - $53.0 $68,449 - $129,797
-2,449 Reduced 16.23%
12,636 $622,000
Q1 2024

Apr 09, 2024

SELL
$32.28 - $41.5 $10,878 - $13,985
-337 Reduced 2.19%
15,085 $517,000
Q4 2023

Jan 04, 2024

SELL
$15.08 - $38.61 $96,692 - $247,567
-6,412 Reduced 29.37%
15,422 $568,000
Q3 2023

Oct 10, 2023

BUY
$18.62 - $26.57 $20,966 - $29,917
1,126 Added 5.44%
21,834 $442,000
Q2 2023

Jul 06, 2023

BUY
$11.49 - $20.46 $56,806 - $101,154
4,944 Added 31.36%
20,708 $423,000
Q1 2023

Apr 06, 2023

BUY
$14.6 - $30.9 $6,102 - $12,916
418 Added 2.72%
15,764 $237,000
Q4 2022

Jan 12, 2023

BUY
$21.92 - $39.37 $15,146 - $27,204
691 Added 4.72%
15,346 $0
Q3 2022

Oct 14, 2022

BUY
$33.44 - $56.56 $55,309 - $93,550
1,654 Added 12.72%
14,655 $516,000
Q2 2022

Jul 08, 2022

BUY
$26.2 - $54.0 $139,724 - $287,982
5,333 Added 69.55%
13,001 $455,000
Q1 2022

Apr 19, 2022

BUY
$38.58 - $83.27 $25,231 - $54,458
654 Added 9.32%
7,668 $379,000
Q4 2021

Jan 12, 2022

BUY
$75.47 - $135.88 $26,112 - $47,014
346 Added 5.19%
7,014 $543,000
Q3 2021

Oct 12, 2021

BUY
$95.64 - $131.48 $115,533 - $158,827
1,208 Added 22.12%
6,668 $713,000
Q2 2021

Jul 22, 2021

BUY
$88.13 - $142.06 $481,189 - $775,647
5,460 New
5,460 $728,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.61B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Green Alpha Advisors, LLC Portfolio

Follow Green Alpha Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Alpha Advisors, LLC with notifications on news.